China kindergarten crisis: How lead in food hospitalised 230 children; understand the dangers, causes and prevention
Tests revealed lead levels thousands of times above the national safety limit. The paint had been purchased online at the instruction of the school principal. Eight individuals, including the principal and key staff, have been arrested.
China reports alarming lead levels in contaminated kindergarten food samples
As BBC reported, authorities revealed that food samples collected from Peixin Kindergarten contained lead levels up to 2,680 times the national safety threshold of 0.5 mg/kg:
Red date cake: 1,052 mg/kg
Corn sausage bun: 1,340 mg/kg
The excessive contamination led to 233 children testing positive for high levels of lead in their blood.
Chinese state media broadcast CCTV footage showing kitchen staff adding the pigment directly into the food preparation process.
Chinese kindergarten staff arrested for using toxic paint in food preparation
According to a police statement, the kindergarten principal instructed kitchen staff to purchase the paint online, fully aware it was not meant for consumption. When children began falling ill, the paint and related supplies were intentionally hidden to avoid detection. Authorities later uncovered the materials during their investigation.
As of now, eight individuals, including the school principal and the kindergarten's primary investor, have been arrested and are facing charges related to the production of toxic and harmful food.
Symptoms reported among the children
Parents started noticing symptoms in their children as early as March, although it took several months for the issue to gain official attention. Reported symptoms include:
Persistent stomach pain
Muscle aches (especially in the legs)
Fatigue and irritability
Lack of appetite
One parent, Mr. Liu, took his child to Xi'an for medical treatment after learning about the issue from other concerned families.
His son is now undergoing a 10-day treatment program, raising concerns about long-term organ damage, particularly to the liver and digestive system.
What is lead poisoning
Lead poisoning occurs when lead builds up in the body, often over months or years. Even small amounts of lead can cause serious health issues—particularly in young children, whose bodies and brains are still developing. Lead exposure can damage the nervous system, impair brain development, and cause behavioral, learning, and physical health problems.
How are people exposed to lead
While the Tianshui case involved food contamination, lead is commonly found in:
Old homes with lead-based paint (used before 1978)
Imported toys, candies, and glazed ceramics
Drinking water from lead pipes
Contaminated soil or dust
Some herbal medicines and traditional remedies
Lead poisoning symptoms
In children:
Cramps
Hyperactivity (restlessness, fidgeting and talking too much)
Learning problems
Changes in behaviour
Headaches
Vomiting
Fatigue
Anemia (not enough hemoglobin in their blood)
In adults:
Headaches
Abdominal pain
Personality changes
Anemia
Numbness in feet and legs
Loss of sex drive
Infertility
Diagnosing and treating lead poisoning
The condition is diagnosed through a blood lead test, which measures the concentration of lead in the bloodstream. As reported by Cleveland Clinic, a level of 5 micrograms per deciliter (µg/dL) or higher is considered a concern in children.
Treatment:
Source removal:
Eliminating further exposure is critical.
Chelation therapy:
For moderate to high levels, medications called chelating agents are used to bind lead in the blood and help the body excrete it.
Whole-bowel irrigation:
Ingested paint chips may be flushed out of the digestive system using a special solution.
Nutritional support:
Diets high in calcium, iron, and vitamin C can help reduce lead absorption.
Prevention against lead poisoning
This case exposes significant gaps in food safety enforcement and institutional oversight in certain regions. While regulations exist, this tragedy underscores the need for more rigorous inspections, staff training, and penalties for negligence.
Steps to prevent lead exposure:
At home:
Test old homes for lead-based paint
Use only certified cookware and toys
Wash hands and toys frequently
Let tap water run before use if you suspect old pipes
Never use hot water from the tap for cooking or baby formula
In schools and daycares:
Ensure that all materials used in kitchens and classrooms are certified safe
Train staff to recognize and avoid hazardous substances
Implement regular inspections and audits
Also Read |
Why chewing 'saunf-mishri' after meals is good for your health
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
8 hours ago
- Time of India
US lawmakers press FDA to target knockoff weight-loss drugs
Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market-a problem that emerged over the last year. Explore courses from Top Institutes in Please select course: Select a Course Category Cybersecurity MCA Data Science Degree Leadership PGDM Public Policy Operations Management others Others Product Management healthcare Digital Marketing MBA Technology Project Management CXO Finance Artificial Intelligence Healthcare Data Analytics Management Design Thinking Data Science Skills you'll gain: Duration: 10 Months MIT xPRO CERT-MIT xPRO PGC in Cybersecurity Starts on undefined Get Details "We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications," they wrote in a letter to FDA commissioner Marty Makary. "Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences." by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play War Thunder now for free War Thunder Play Now Undo The group-spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey-asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the "urgency" of the situation. Live Events A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a "complete and thorough" response to the issues raised in the lawmakers' letter. "Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously," the spokesperson said. "And we are deeply committed to strengthening the oversight of imported products at US ports of entry." In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalise on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage but are no longer permitted to do so after Novo Nordisk and Eli Lilly boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalisations potentially linked to the copycat drugs, but that adverse events are likely being underreported. "We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs," said a spokesperson for Hims & Hers Health, one of the telehealth firms that sells compounded GLP-1s. "We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first." Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments.
Mint
11 hours ago
- Mint
Lawmakers Press FDA to Target Knockoff Weight-Loss Drugs
(Bloomberg) -- Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid mounting concerns over their potential safety risks. On Friday, a group of more than 80 bipartisan lawmakers asked the US Food and Drug Administration to stop counterfeit and copycat versions of GLP-1 drugs like Wegovy and Zepbound from flooding the market — a problem that emerged over the last year. 'We are concerned about recent reports revealing a surge in illegal and counterfeit anti-obesity medications,' they wrote in a letter to FDA Commissioner Marty Makary. 'Undoubtedly, illegal counterfeit medications pose an increased risk to patient safety with sometimes fatal consequences.' The group — spearheaded by Representatives Richard Hudson of North Carolina and Herb Conaway of New Jersey — asked the agency to ramp up enforcement over illegally imported weight-loss drugs. They suggested issuing warning letters and better monitoring non-compliant online retailers and so-called compounding pharmacies that sell the medicines. The lawmakers also said the FDA should work in tandem with US Customs and Border Patrol agents to stop Chinese entities from shipping unsafe weight-loss drugs into the US. They requested an update on the FDA's efforts by July 30, given the 'urgency' of the situation. A spokesperson for the FDA said the agency will work with the US Department of Health and Human Services to provide a 'complete and thorough' response to the issues raised in the lawmakers' letter. 'Any effort to undermine America's supply of safe medicines is an issue that FDA takes seriously,' the spokesperson said. 'And we are deeply committed to strengthening the oversight of imported products at US ports of entry.' In recent years, the popularity of GLP-1 drugs has led to an explosion of copycats and counterfeits made by companies seeking to capitalize on the hype. State-licensed pharmacies were temporarily allowed to make copies of the drugs during a supply shortage, but are no longer permitted to do so after Novo Nordisk A/S and Eli Lilly & Co. boosted production. Still, some pharmacies have refused to wind down their operations while others have pivoted to selling the drugs in lower doses in order to avoid regulatory scrutiny. Counterfeit drugs are made by unregistered entities typically using illegally imported ingredients. As recently as April, there continue to be instances when counterfeit Ozempic pens covertly enter the drug supply chain undetected. Some patients are also purchasing ingredients directly from online sellers in an attempt to make the drugs themselves at home. In both cases, the medications don't go through the same rigorous approval process as brand-name drugs made by Novo and Lilly. Experts worry the lack of oversight is putting patients at risk. The FDA has said it's aware of hospitalizations potentially linked to the copycat drugs, but that adverse events are likely being underreported. 'We support the bi-partisan call for the FDA to crack down on counterfeit and illegally sold weight-loss drugs,' said a spokesperson for Hims & Hers Health Inc., one of the telehealth firms that sells compounded GLP-1s. 'We appreciate lawmakers' recognition that legitimate compounded medications dispensed by state-regulated pharmacies are not counterfeit. Patient safety must always come first.' Novo and Lilly have discouraged consumers from using compounded and counterfeit products, including suing telehealth firms that sell the copycat versions and working with border agents to seize illegal shipments. Under the Biden administration, the companies repeatedly urged the FDA to take action, but the agency mostly limited its actions to issuing consumer warnings — even as its top drug official publicly acknowledged safety concerns. Under the Trump administration, the HHS has also focused more heavily on other issues, such as banning food dyes and examining vaccine schedules. Meanwhile, lawmakers are ramping up their calls for action. State attorneys and other lawmakers have sent letters to the FDA and Federal Trade Commission advocating for greater transparency around the treatments and more scrutiny around marketing practices. (Updates with statement from FDA in sixth and seventh paragraphs.) More stories like this are available on
News18
11 hours ago
- News18
‘Came With Skills, Heart': Bangladesh's Yunus To Indian, Chinese Doctors Treating Crash Victims
Last Updated: The international medical teams are currently in Dhaka to provide specialised care to those injured in the recent plane crash, many of whom are children Bangladesh's interim leader Muhammad Yunus on Sunday thanked doctors and nurses from India, China, and Singapore for their support in treating victims of the recent plane crash in Dhaka. In a post on the social media platform X, Yunus said that a delegation of 21 doctors and nurses from the three countries met him at the State Guest House Jamuna in Dhaka. The international medical teams are in the capital to provide specialised care to those injured in the crash at Milestone School and College, many of whom are children. The crash took place on Monday when a Chinese-made F-7 BGI training fighter jet suffered a mechanical fault shortly after take-off and crashed into a two-storey school building, killing 32 people, including 26 children. 'These teams have come not just with their skills, but with their hearts," Yunus said during the meeting. 'Their presence reaffirms our shared humanity and the value of global partnerships in times of tragedy." Chief Adviser thanks foreign medical teams for treating plane crash victimsDhaka, July 27, 2025: A delegation of 21 physicians and nurses from Singapore, China, and India met with Chief Adviser Professor Muhammad Yunus on Sunday at the State Guest House Jamuna. The… — Chief Adviser of the Government of Bangladesh (@ChiefAdviserGoB) July 27, 2025 The interim leader praised the teams' quick response and dedication during a national crisis and assured the visiting medical professionals of the government's full support in helping them carry out their mission. He also urged the doctors to build long-term ties with Bangladesh, including virtual cooperation in areas such as institutional collaboration, medical education exchange, and capacity building in the health sector. 'He emphasised that such partnerships could lay the foundation for lasting cooperation in public health and emergency preparedness," the post added. The delegation included ten members from Singapore, eight from China, and four from India. Chinese Ambassador to Dhaka Yao Wen and the Head of Mission from Singapore also attended the meeting. Meanwhile, an Indian medical team had arrived in Dhaka on Wednesday to assist in treating the victims of the crash. Prime Minister Narendra Modi had also expressed his condolences over the loss of life and offered support and assistance to Bangladesh following the tragedy. view comments Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
